Cancer Drug May Boost Risk of Gastrointestinal Perforation
5/25/2009
HealthDay - MONDAY, May 25 (HealthDay News) -- The use of the drug bevacizumab
(Avastin) in meld with chemotherapy greatly increases the risk of
gastrointestinal perforations in cancer patients, new delving has
found.
More: - Read the rest here
Share and enjoy
Post Comment
Entry 1 of 16100
Last Page | Next Page